If overwhelming efficacy is demonstrated at an interim readout then the trial has to be halted and the placebo patients offered the treatment. Clearly immoral not to do so ... also a legal minefield if this was not done.
- Forums
- ASX - By Stock
- MSB
- Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-216
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
0.015(1.52%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
99.5¢ | $1.01 | 98.5¢ | $450.5K | 454.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 56430 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 50548 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 8391 | 0.995 |
15 | 103071 | 0.990 |
12 | 100416 | 0.985 |
17 | 250066 | 0.980 |
5 | 72012 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 27568 | 4 |
1.005 | 32016 | 8 |
1.010 | 38690 | 6 |
1.015 | 126242 | 4 |
1.020 | 75986 | 3 |
Last trade - 10.33am 15/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online